Trial reportBMC anesthesiology2026
Comparison of esketamine combined with dexmedetomidine versus propofol combined with midazolam on drug-induced sleep endoscopy: a randomized controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDrug-induced sleep endoscopy (DISE) is widely used to evaluate upper airway obstruction in patients with obstructive sleep apnea syndrome (OSAS). We aimed to compare the sedative efficacy and safety of esketamine combined with dexmedetomidine versus propofol combined with midazolam for sedation in patients undergoing DISE.
methodsThis prospective, single-center, assessor-blinded, randomized controlled trial was conducted among patients scheduled for DISE between July 2025 and December 2025. Participants were enrolled and randomized into two groups: the experimental group (esketamine-dexmedetomidine) and the control group (propofol-midazolam). Polysomnography (PSG) was used to determine sleep stages, and the bispectral index (BIS) was used to assess sedation depth. Endoscopy was initiated after patients reached non-rapid eye movement sleep stage 2 (N2). The primary outcome was the time required to reach N2 sleep confirmed by PSG. Secondary outcomes included the first-pass success rate, BIS values, oxygen saturation (SpO₂), and the incidence of adverse events (body movement, hypoxemia, tachycardia, bradycardia, and other procedure-related events) during the procedure.
resultsA total of 50 patients were enrolled and randomly assigned to the experimental group (n = 25) or the control group (n = 25). All patients successfully completed the DISE procedure and achieved N2 sleep confirmed by PSG. The time required to reach N2 sleep was slightly shorter in the experimental group than in the control group, with median (interquartile range [IQR]) values of 188.0 (170.0-229.0) seconds and 214.0 (189.0-253.5) seconds, respectively; however, this difference did not reach statistical significance (p = 0.067). Meanwhile, preliminary exploratory analyses showed a higher first-pass success rate (96% vs. 36%; unadjusted p < 0.001) and a lower incidence of hypoxemia (20% vs. 48%; unadjusted p < 0.05) in the experimental group during the procedure.
conclusionsEsketamine-dexmedetomidine and propofol-midazolam effectively induced N2 sleep and allowed completion of DISE. Exploratory analyses suggest that the esketamine-dexmedetomidine regimen may potentially improve procedural conditions and respiratory safety, though these findings are hypothesis-generating and require confirmation in larger, adequately powered studies.
trial registrationChinese Clinical Trial Registry (ChiCTR2500102931), first registered on 05/21/2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.